Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherBrowse by ChannelAbout the NetworkJoin the NetworkProductsSub-MenuProducts OverviewBlog ProBlog PlusBlog PremierMicrositeSyndication PortalsAbout UsContactSubscribeSupport
Book a Demo
Search
Close

Update on Regeneron’s Supplemental BLA for EYLEA HD

April 29, 2025

FDA Approves Celltrion’s STEQEYMA (ustekinumab-stba)

January 6, 2025

European Commission Approves Samsung Bioepis and Biogen’s Aflibercept Biosimilar

November 27, 2024

Accord Biopharma Announces FDA Approval of IMULDOSA (ustekinumab-srlf)

October 24, 2024

FDA Seeks Input on Biosimilar Product Development Guidance

August 20, 2024

FDA Approves Moderna’s mRESVIA Vaccine

June 6, 2024

FDA Launches Support for Clinical Trials Advancing Rare Disease Therapeutics (START) Pilot Program

June 4, 2024

Alvotech Announces More Settlements and Expected Launch Dates Regarding Biosimilar to STELARA (ustekinumab), AVT04

February 23, 2024

Alvotech and STADA obtain approval in Europe for ustekinumab biosimilar, UZPRUVO

January 18, 2024
Subscribe: Subscribe via RSS
Blogs
  • Big Molecule Watch
Firm/Org
  • Goodwin Procter

Daniel Farraye

Subscribe: Subscribe via RSS
Blogs
  • Big Molecule Watch
Firm/Org
  • Goodwin Procter
LexBlog, Inc. logo
Facebook LinkedIn Twitter RSS
Real Lawyers
99 Park Row
  • About LexBlog
  • Careers
  • Press
  • Contact LexBlog
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Terms of Service
  • RSS Terms of Service
  • Products
  • Blog Pro
  • Blog Plus
  • Blog Premier
  • Microsite
  • Syndication Portals
  • LexBlog Community
  • Resource Center
  • 1-800-913-0988
  • Submit a Request
  • Support Center
  • System Status
  • Resource Center
  • Blogging 101

New to the Network

  • Tennessee Insurance Litigation Blog
  • Claims & Sustains
  • New Jersey Restraining Order Lawyers
  • New Jersey Gun Lawyers
  • Blog of Reason
Copyright © 2025, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo